The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6527777 7217352 F 2 6527777-3 20091104 20091221 20091231 EXP 8054510 UCB, INC. 35 N 60 KG 20091230 SERBIA

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6527777 1012904016 PS CERTOLIZUMAB PEGOL (CERTOLIZUMAB PEGOL) 2 SUBCUTANEOUS (200 MG 1X/2 WEEKS SUBCUTANEOUS), (400 MG QOD, - NR OF DOSES :31 SUBCUTANEOUS), ( 200 MG 1X/2 WEEKS, Y

Indications of drugs used

Event ID DRUG SEQ INDI PT
6527777 1012904016 RHEUMATOID ARTHRITIS

Outcome of event

Event ID OUTC COD
6527777 OT

Reactions reported

Event ID PT
6527777 ESCHERICHIA URINARY TRACT INFECTION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6527777 FGN
6527777 HP
6527777 OTH
6527777 SDY

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6527777 1012904016 20051228 20060612
6527777 1012904016 20060612 20071211
6527777 1012904016 20071225 20091110
6527777 1012904016 20091208